Trial intelligence / Profile preview

Pravastatin in HIV-infected Patients Treated With Highly Active Antiretroviral Therapy

NCT00221754Phase 2Completed

Sponsor
Centre Hospitalier Universitaire de Bordeaux
Start
Mar 2003
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, randomised, double-blind trial in hypercholesterolemia comparing Pravastatin with Placebo (2 arms). Primary endpoint: HIV RNA at 12 weeks. Started Mar 2003; status: completed.

02

Drugs

pravastatin
03

Conditions

hypercholesterolemia

Beyond the preview

Go deeper on NCT00221754.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00221754.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call